Document is current

Article History

Received: 29 October 2024

Accepted: 14 February 2025

First Online: 12 March 2025

Declarations

:

: Riccardo Sacconi is a consultant for Allergan Inc (Irvine, CA, USA), Bayer Schering-Pharma (Berlin, Germany), Carl Zeiss Meditec (Dublin, CA, USA), Novartis (Basel, Switzerland), Roche (Basel, Switzerland). Francesco Bandello is a consultant for Alcon (Fort Worth, TX, USA), Alimera Sciences (Alpharetta, GA, USA), Allergan Inc (Irvine, CA, USA), Farmila-Thea (Clermont-Ferrand, France), Bayer Schering-Pharma (Berlin, Germany), Bausch And Lomb (Rochester, NY, USA), Genentech (San Francisco, CA, USA), Hoffmann-La-Roche (Basel, Switzerland), Novagali Pharma (Évry, France), Novartis (Basel, Switzerland), Sanofi-Aventis (Paris, France), Thrombogenics (Heverlee, Belgium), Zeiss (Dublin, CA, USA). Giuseppe Querques is a consultant for Alimera Sciences (Alpharetta, GA, USA), Allergan Inc (Irvine, CA, USA), Amgen (Thousand Oaks, CA, USA), Heidelberg (Germany), KBH (Chengdu, China), LEH Pharma (London, UK), LumiThera (Poulsbo, WA, USA), Novartis (Basel, Switzerland), Bayer Schering-Pharma (Berlin, Germany), Sandoz (Berlin, Germany), Sifi (Catania, Italy), Soof-Fidia (Albano, Italy), Zeiss (Dublin, CA, USA). Giuseppe Querques is an Editorial Board member of Ophthalmology and Therapy. Giuseppe Querques was not involved in the selection of peer reviewers for the manuscript nor any of the subsequent editorial decisions. Simone Marra, Elena Spada, Federico Beretta, Matteo Menna, and Stefano Menecozzi have nothing to disclose.

: All included patients signed a written informed consent for the retrospective study that was previously approved by San Raffaele Ethics Committee. However, due to the retrospective and observational nature of the study, the study does not require a specific Ethics Committee Approval in line with Italian laws. The study followed the tenets outlined in the Declaration of Helsinki for research involving human subjects.